Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial - Concepedia

Concepedia

Publication | Closed Access

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

136

Citations

22

References

2023

Year

Richard B. Lipton, Robert Croop, David Stock, Jennifer Madonia, Micaela Forshaw, Meghan Lovegren, Linda Mosher, Vladimir Coric, Peter J. Goadsby

The Lancet Neurology

Cluster HeadachePharmacotherapyNeurologyMg Nasal SprayMedicineZavegepant 10Phase 3

References

	Year	Citations

Page 1